Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Lars Klareskog

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Geographic Areas

Sweden

Living Beings

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Askling Johan; van Vollenhoven Ronald F; Granath Fredrik; Raaschou Pauline; Fored C Michael; Baecklund Eva; Dackhammar Christina; Feltelius Nils; Cöster Lars; Geborek Pierre; Jacobsson Lennart T; Lindblad Staffan; Rantapää-Dahlqvist Solbritt; Saxne Tore; Klareskog Lars
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: Does the risk change with the time since start of treatment?
Rioux John D; Goyette Philippe; Vyse Timothy J; Hammarström Lennart; Fernando Michelle M A; Green Todd; De Jager Philip L; Foisy Sylvain; Wang Joanne; de Bakker Paul I W; Leslie Stephen; McVean Gilean; Padyukov Leonid; Alfredsson Lars; Annese Vito; Hafler David A; Pan-Hammarström Qiang; Matell Ritva; Sawcer Stephen J; Compston Alastair D; Cree Bruce A C; Mirel Daniel B; Daly Mark J; Behrens Tim W; Klareskog Lars; Gregersen Peter K; Oksenberg Jorge R; Hauser Stephen L
Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases.
Rosell Magdalena; Wesley Ann-Marie; Rydin Karin; Klareskog Lars; Alfredsson Lars;
Dietary fish and fish oil and the risk of rheumatoid arthritis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Lars Klareskog (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Askling Johan; van Vollenhoven Ronald F; Granath Fredrik; Raaschou Pauline; Fored C Michael; Baecklund Eva; Dackhammar Christina; Feltelius Nils; Cöster Lars; Geborek Pierre; Jacobsson Lennart T; Lindblad Staffan; Rantapää-Dahlqvist Solbritt; Saxne Tore; Klareskog Lars
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: Does the risk change with the time since start of treatment?
Arthritis and rheumatism 2009;60(11):3180-9.
2009: Rioux John D; Goyette Philippe; Vyse Timothy J; Hammarström Lennart; Fernando Michelle M A; Green Todd; De Jager Philip L; Foisy Sylvain; Wang Joanne; de Bakker Paul I W; Leslie Stephen; McVean Gilean; Padyukov Leonid; Alfredsson Lars; Annese Vito; Hafler David A; Pan-Hammarström Qiang; Matell Ritva; Sawcer Stephen J; Compston Alastair D; Cree Bruce A C; Mirel Daniel B; Daly Mark J; Behrens Tim W; Klareskog Lars; Gregersen Peter K; Oksenberg Jorge R; Hauser Stephen L
Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(44):18680-5.
2009: Rosell Magdalena; Wesley Ann-Marie; Rydin Karin; Klareskog Lars; Alfredsson Lars;
Dietary fish and fish oil and the risk of rheumatoid arthritis.
Epidemiology (Cambridge, Mass.) 2009;20(6):896-901.
2009: Tian Chao; Kosoy Roman; Nassir Rami; Lee Annette; Villoslada Pablo; Klareskog Lars; Hammarström Lennart; Garchon Henri-Jean; Pulver Ann E; Ransom Michael; Gregersen Peter K; Seldin Michael F
European population genetic substructure: further definition of ancestry informative markers for distinguishing among diverse European ethnic groups.
Molecular medicine (Cambridge, Mass.) 2009;15(11-12):371-83.
2009: Holmqvist Marie E; Wedrén Sara; Jacobsson Lennart T H; Klareskog Lars; Nyberg Fredrik; Rantapää-Dahlqvist Solbritt; Alfredsson Lars; Askling Johan
No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts.
Arthritis and rheumatism 2009;60(10):2861-9.
2009: Lundström Emeli; Källberg Henrik; Alfredsson Lars; Klareskog Lars; Padyukov Leonid
Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important.
Arthritis and rheumatism 2009;60(6):1597-603.
2009: Svelander Lena; Erlandsson-Harris Helena; Astner Leif; Grabowska Urszula; Klareskog Lars; Lindstrom Erik; Hewitt Ellen
Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice.
European journal of pharmacology 2009;613(1-3):155-62.
2009: Lee Yvonne C; Raychaudhuri Soumya; Cui Jing; De Vivo Immaculata; Ding Bo; Alfredsson Lars; Padyukov Leonid; Costenbader Karen H; Seielstad Mark; Graham Robert R; Klareskog Lars; Gregersen Peter K; Plenge Robert M; Karlson Elizabeth W
The PRL -1149 G/T polymorphism and rheumatoid arthritis susceptibility.
Arthritis and rheumatism 2009;60(5):1250-4.
2009: Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables P J; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Annals of the rheumatic diseases 2009;68(5):736-43.
2009: Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Cöster L; Jacobsson L T; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
Annals of the rheumatic diseases 2009;68(5):648-53.
2009: Lundström Emeli; Källberg Henrik; Smolnikova Marina; Ding Bo; Rönnelid Johan; Alfredsson Lars; Klareskog Lars; Padyukov Leonid
Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
Arthritis and rheumatism 2009;60(4):924-30.
2009: Klareskog Lars; Wedrén Sara; Alfredsson Lars
On the origins of complex immune-mediated disease: the example of rheumatoid arthritis.
Journal of molecular medicine (Berlin, Germany) 2009;87(4):357-62.
2009: Liao Katherine P; Gunnarsson Marie; Källberg Henrik; Ding Bo; Plenge Robert M; Padyukov Leonid; Karlson Elizabeth W; Klareskog Lars; Askling Johan; Alfredsson Lars
Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis.
Arthritis and rheumatism 2009;60(3):653-60.
2009: Klareskog Lars; Catrina Anca Irinel; Paget Stephen
Rheumatoid arthritis.
Lancet 2009;373(9664):659-72.
2009: Källberg H; Jacobsen S; Bengtsson C; Pedersen M; Padyukov L; Garred P; Frisch M; Karlson E W; Klareskog L; Alfredsson L
Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies.
Annals of the rheumatic diseases 2009;68(2):222-7.
2009: Ding Bo; Padyukov Leonid; Lundström Emeli; Seielstad Mark; Plenge Robert M; Oksenberg Jorge R; Gregersen Peter K; Alfredsson Lars; Klareskog Lars
Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region.
Arthritis and rheumatism 2009;60(1):30-8.
2009: af Klint Erik; Catrina Anca I; Matt Peter; Neregråd Petra; Lampa Jon; Ulfgren Ann-Kristin; Klareskog Lars; Lindblad Staffan
Evaluation of arthroscopy and macroscopic scoring.
Arthritis research & therapy 2009;11(3):R81.
2009: Hueber Wolfgang; Tomooka Beren H; Batliwalla Franak; Li Wentian; Monach Paul A; Tibshirani Robert J; Van Vollenhoven Ronald F; Lampa Jon; Saito Kazuyoshi; Tanaka Yoshiya; Genovese Mark C; Klareskog Lars; Gregersen Peter K; Robinson William H
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis.
Arthritis research & therapy 2009;11(3):R76.
2009: Bengtsson Camilla; Theorell Tores; Klareskog Lars; Alfredsson Lars
Psychosocial stress at work and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
Psychotherapy and psychosomatics 2009;78(3):193-4.
2008: Vallerskog Therese; Gaines Hans; Feldman Adina; Culbert Eric; Klareskog Lars; Malmström Vivianne; Trollmo Christina
Serial re-challenge with influenza vaccine as a tool to study individual immune responses.
Journal of immunological methods 2008;339(2):165-74.
2008: Catrina Anca Irinel; Klareskog Lars
Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al.
Arthritis and rheumatism 2008;59(11):1685; author reply 1685-6.
2008: van der Helm-van Mil Annette H M; Padyukov Leonid; Toes René E M; Klareskog Lars; Huizinga Tom W J
Genome-wide single-nucleotide polymorphism studies in rheumatology: Hype or hope?
Arthritis and rheumatism 2008;58(9):2591-7.
2008: Gu Ming; Kakoulidou Maria; Giscombe Ricardo; Pirskanen Ritva; Lefvert Ann Kari; Klareskog Lars; Wang XiongBiao
Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis.
Clinical immunology (Orlando, Fla.) 2008;128(3):374-81.
2008: van der Heijde D; Landewé R; van Vollenhoven R; Fatenejad S; Klareskog L
Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial.
Annals of the rheumatic diseases 2008;67(9):1267-70.
2008: Klareskog Lars; Widhe Mona; Hermansson Monika; Rönnelid Johan
Antibodies to citrullinated proteins in arthritis: pathology and promise.
Current opinion in rheumatology 2008;20(3):300-5.
2008: Baecklund Eva; Natkunam Yasodha; Backlin Carin; Iliadou Anastasia; Askling Johan; Ekbom Anders; Feltelius Nils; Klareskog Lars; Enblad Gunilla; Lossos Izidore S; Levy Ronald; Sundström Christer; Rosenquist Richard
Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.
British journal of haematology 2008;141(1):69-72.
2008: Westman E; Thi Ngoc D D; Klareskog L; Harris H Erlandsson
Suppressive effects of a quinoxaline-analogue (Rob 803) on pathogenic immune mechanisms in collagen-induced arthritis.
Clinical and experimental immunology 2008;152(1):192-9.
2008: Jónsdóttir T; Gunnarsson I; Risselada A; Henriksson E W; Klareskog L; van Vollenhoven R F
Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response.
Annals of the rheumatic diseases 2008;67(3):330-4.
2008: Tracey Daniel; Klareskog Lars; Sasso Eric H; Salfeld Jochen G; Tak Paul P
Tumor necrosis factor antagonist mechanisms of action: a comprehensive review.
Pharmacology & therapeutics 2008;117(2):244-79.
2008: Tian Chao; Plenge Robert M; Ransom Michael; Lee Annette; Villoslada Pablo; Selmi Carlo; Klareskog Lars; Pulver Ann E; Qi Lihong; Gregersen Peter K; Seldin Michael F
Analysis and application of European genetic substructure using 300 K SNP information.
PLoS genetics 2008;4(1):e4.
2008: Mathsson Linda; Mullazehi Mohammed; Wick Marius C; Sjöberg Olof; van Vollenhoven Ronald; Klareskog Lars; Rönnelid Johan
Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Arthritis and rheumatism 2008;58(1):36-45.
2008: Cohen Irun R; Klareskog Lars
Antiinflammatory therapy for rheumatoid arthritis?
Arthritis and rheumatism 2008;58(1):2-4.
2008: Klareskog Lars; Rönnelid Johan; Lundberg Karin; Padyukov Leonid; Alfredsson Lars
Immunity to citrullinated proteins in rheumatoid arthritis.
Annual review of immunology 2008;26():651-75.
2007: van der Heijde D; Klareskog L; Landewé R; Bruyn G A W; Cantagrel A; Durez P; Herrero-Beaumont G; Molad Y; Codreanu C; Valentini G; Zahora R; Pedersen R; MacPeek D; Wajdula J; Fatenejad S
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
Arthritis and rheumatism 2007;56(12):3928-39.
2007: van Vollenhoven R F; Klareskog L
Infliximab dosage and infusion frequency in clinical practice: experiences in the Stockholm biologics registry STURE.
Scandinavian journal of rheumatology 2007;36(6):418-23.
2007: Zhang Angela L; Colmenero Paula; Purath Ulrich; Teixeira de Matos Cristina; Hueber Wolfgang; Klareskog Lars; Tarner Ingo H; Engleman Edgar G; Söderström Kalle
Natural killer cells trigger differentiation of monocytes into dendritic cells.
Blood 2007;110(7):2484-93.
2007: Askling Johan; Fored C Michael; Brandt Lena; Baecklund Eva; Bertilsson Lennart; Feltelius Nils; Cöster Lars; Geborek Pierre; Jacobsson Lennart T; Lindblad Staffan; Lysholm Jörgen; Rantapää-Dahlqvist Solbritt; Saxne Tore; van Vollenhoven Ronald F; Klareskog Lars
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists.
Annals of the rheumatic diseases 2007;66(10):1339-44.
2007: Tengstrand B; Larsson E; Klareskog L; Hafström I
Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density.
Scandinavian journal of rheumatology 2007;36(5):351-8.
2007: Kurreeman Fina A S; Padyukov Leonid; Marques Rute B; Schrodi Steven J; Seddighzadeh Maria; Stoeken-Rijsbergen Gerrie; van der Helm-van Mil Annette H M; Allaart Cornelia F; Verduyn Willem; Houwing-Duistermaat Jeanine; Alfredsson Lars; Begovich Ann B; Klareskog Lars; Huizinga Tom W J; Toes Rene E M
A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.
PLoS medicine 2007;4(9):e278.
2007: Remmers Elaine F; Plenge Robert M; Lee Annette T; Graham Robert R; Hom Geoffrey; Behrens Timothy W; de Bakker Paul I W; Le Julie M; Lee Hye-Soon; Batliwalla Franak; Li Wentian; Masters Seth L; Booty Matthew G; Carulli John P; Padyukov Leonid; Alfredsson Lars; Klareskog Lars; Chen Wei V; Amos Christopher I; Criswell Lindsey A; Seldin Michael F; Kastner Daniel L; Gregersen Peter K
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.
The New England journal of medicine 2007;357(10):977-86.
2007: Plenge Robert M; Seielstad Mark; Padyukov Leonid; Lee Annette T; Remmers Elaine F; Ding Bo; Liew Anthony; Khalili Houman; Chandrasekaran Alamelu; Davies Leela R L; Li Wentian; Tan Adrian K S; Bonnard Carine; Ong Rick T H; Thalamuthu Anbupalam; Pettersson Sven; Liu Chunyu; Tian Chao; Chen Wei V; Carulli John P; Beckman Evan M; Altshuler David; Alfredsson Lars; Criswell Lindsey A; Amos Christopher I; Seldin Michael F; Kastner Daniel L; Klareskog Lars; Gregersen Peter K
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.
The New England journal of medicine 2007;357(12):1199-209.
2007: Lorentzen Johnny C; Flornes Line; Eklöw Carina; Bäckdahl Liselotte; Ribbhammar Ulrica; Guo Jian Ping; Smolnikova Marina; Dissen Erik; Seddighzadeh Maria; Brookes Anthony J; Alfredsson Lars; Klareskog Lars; Padyukov Leonid; Fossum Sigbjörn
Association of arthritis with a gene complex encoding C-type lectin-like receptors.
Arthritis and rheumatism 2007;56(8):2620-32.
2007: Sigurdsson Snaevar; Padyukov Leonid; Kurreeman Fina A S; Liljedahl Ulrika; Wiman Ann-Christin; Alfredsson Lars; Toes René; Rönnelid Johan; Klareskog Lars; Huizinga Tom W J; Alm Gunnar; Syvänen Ann-Christine; Rönnblom Lars
Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis.
Arthritis and rheumatism 2007;56(7):2202-10.
2007: Kallberg Henrik; Padyukov Leonid; Plenge Robert M; Ronnelid Johan; Gregersen Peter K; van der Helm-van Mil Annette H M; Toes Rene E M; Huizinga Tom W; Klareskog Lars; Alfredsson Lars;
Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis.
American journal of human genetics 2007;80(5):867-75.
2007: Trollmo Christina; Gudmundsson Sveinn; Feltelius Nils; Rogberg Siv; Smedegård Göran; Klareskog Lars
Sulphasalazine inhibits human antigen-specific immune responses in vivo.
Annals of the rheumatic diseases 2007;66(4):481-5.
2007: van der Heijde Désirée; Klareskog Lars
Reply to letter by Yazici and Yazici commenting on the two-year report on the trial of etanercept and methotrexate with radiographic and patient outcomes.
Arthritis and rheumatism 2007;56(3):1031-2.
2007: Carlens Cecilia; Brandt Lena; Klareskog Lars; Lampa Jon; Askling Johan
The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomy.
Annals of the rheumatic diseases 2007;66(3):414-6.
2007: Klareskog Lars; Padyukov Leonid; Alfredsson Lars
Smoking as a trigger for inflammatory rheumatic diseases.
Current opinion in rheumatology 2007;19(1):49-54.
2007: Vallerskog Therese; Gunnarsson Iva; Widhe Mona; Risselada Anke; Klareskog Lars; van Vollenhoven Ronald; Malmström Vivianne; Trollmo Christina
Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.
Clinical immunology (Orlando, Fla.) 2007;122(1):62-74.
2007: Olsson Lina M; Lindqvist Anna-Karin; Källberg Henrik; Padyukov Leonid; Burkhardt Harald; Alfredsson Lars; Klareskog Lars; Holmdahl Rikard
A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity.
Arthritis research & therapy 2007;9(5):R98.
2006: Lichtenstein Paul; Sullivan Patrick F; Cnattingius Sven; Gatz Margaret; Johansson Sofie; Carlström Eva; Björk Camilla; Svartengren Magnus; Wolk Alicja; Klareskog Lars; de Faire Ulf; Schalling Martin; Palmgren Juni; Pedersen Nancy L
The Swedish Twin Registry in the third millennium: an update.
Twin research and human genetics : the official journal of the International Society for Twin Studies 2006;9(6):875-82.
2006: Baecklund Eva; Backlin Carin; Iliadou Anastasia; Granath Fredrik; Ekbom Anders; Amini Rose-Marie; Feltelius Nils; Enblad Gunilla; Sundström Christer; Klareskog Lars; Askling Johan; Rosenquist Richard
Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis.
Arthritis and rheumatism 2006;54(12):3774-81.
2006: Klareskog Lars; Padyukov Leonid; Rönnelid Johan; Alfredsson Lars
Genes, environment and immunity in the development of rheumatoid arthritis.
Current opinion in immunology 2006;18(6):650-5.
2006: Klareskog L; Gaubitz M; Rodriguez-Valverde V; Malaise M; Dougados M; Wajdula J;
A long-term, open-label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease-modifying antirheumatic drugs.
Annals of the rheumatic diseases 2006;65(12):1578-84.
2006: Klareskog Lars
Clinical databases and biobanks for etiologic and therapeutic studies in rheumatoid arthritis.
Nature clinical practice. Rheumatology 2006;2(10):517.
2006: Landewé Robert; van der Heijde Désirée; Klareskog Lars; van Vollenhoven Ronald; Fatenejad Saeed
Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
Arthritis and rheumatism 2006;54(10):3119-25.
2006: Seldin Michael F; Shigeta Russell; Villoslada Pablo; Selmi Carlo; Tuomilehto Jaakko; Silva Gabriel; Belmont John W; Klareskog Lars; Gregersen Peter K
European population substructure: clustering of northern and southern populations.
PLoS genetics 2006;2(9):e143.
2006: Makrygiannakis D; af Klint E; Lundberg I E; Löfberg R; Ulfgren A-K; Klareskog L; Catrina A I
Citrullination is an inflammation-dependent process.
Annals of the rheumatic diseases 2006;65(9):1219-22.
2006: Askling J; Klareskog L; Blomqvist P; Fored M; Feltelius N
Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study.
Annals of the rheumatic diseases 2006;65(9):1184-7.
2006: Klareskog Lars; Padyukov Leonid; Lorentzen Johnny; Alfredsson Lars
Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis.
Nature clinical practice. Rheumatology 2006;2(8):425-33.
2006: Cao D; Börjesson O; Larsson P; Rudin A; Gunnarsson I; Klareskog L; Malmström V; Trollmo C
FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints.
Scandinavian journal of immunology 2006;63(6):444-52.
2006: Askling J; Fored C M; Geborek P; Jacobsson L T H; van Vollenhoven R; Feltelius N; Lindblad S; Klareskog L
Swedish registers to examine drug safety and clinical issues in RA.
Annals of the rheumatic diseases 2006;65(6):707-12.
2006: Björnådal L; Brandt L; Klareskog L; Askling J
Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis.
Annals of the rheumatic diseases 2006;65(6):741-5.
2006: Makrygiannakis Dimitrios; af Klint Erik; Catrina Sergiu-Bogdan; Botusan Ileana Ruxandra; Klareskog Elin; Klareskog Lars; Ulfgren Ann-Kristin; Catrina Anca Irinel
Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis.
Arthritis and rheumatism 2006;54(5):1463-72.
2006: van der Heijde Désirée; Klareskog Lars; Rodriguez-Valverde Vicente; Codreanu Catalin; Bolosiu Horatiu; Melo-Gomes Jose; Tornero-Molina Jesus; Wajdula Joseph; Pedersen Ronald; Fatenejad Saeed;
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
Arthritis and rheumatism 2006;54(4):1063-74.
2006: Baecklund Eva; Iliadou Anastasia; Askling Johan; Ekbom Anders; Backlin Carin; Granath Fredrik; Catrina Anca Irinel; Rosenquist Richard; Feltelius Nils; Sundström Christer; Klareskog Lars
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.
Arthritis and rheumatism 2006;54(3):692-701.
2006: van der Heijde D; Klareskog L; Singh A; Tornero J; Melo-Gomes J; Codreanu C; Pedersen R; Freundlich B; Fatenejad S
Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
Annals of the rheumatic diseases 2006;65(3):328-34.
2006: Nordmark B; Blomqvist P; Andersson B; Hägerström M; Nordh-Grate K; Rönnqvist R; Svensson H; Klareskog L
A two-year follow-up of work capacity in early rheumatoid arthritis: a study of multidisciplinary team care with emphasis on vocational support.
Scandinavian journal of rheumatology 2006;35(1):7-14.
2006: Catrina Anca Irinel; af Klint Erik; Ernestam Sofia; Catrina Sergiu-Bogdan; Makrygiannakis Dimitrios; Botusan Ileana Ruxandra; Klareskog Lars; Ulfgren Ann-Kristin
Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
Arthritis and rheumatism 2006;54(1):76-81.
2006: Klareskog Lars; Stolt Patrik; Lundberg Karin; Källberg Henrik; Bengtsson Camilla; Grunewald Johan; Rönnelid Johan; Harris Helena Erlandsson; Ulfgren Ann-Kristin; Rantapää-Dahlqvist Solbritt; Eklund Anders; Padyukov Leonid; Alfredsson Lars
A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.
Arthritis and rheumatism 2006;54(1):38-46.
2006: Lindberg Johan; af Klint Erik; Catrina Anca Irinel; Nilsson Peter; Klareskog Lars; Ulfgren Ann-Kristin; Lundeberg Joakim
Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients.
Arthritis research & therapy 2006;8(6):R179.
2006: Lindberg Johan; af Klint Erik; Ulfgren Ann-Kristin; Stark André; Andersson Tove; Nilsson Peter; Klareskog Lars; Lundeberg Joakim
Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology.
Arthritis research & therapy 2006;8(2):R47.
2006: Ernestam Sofia; af Klint Erik; Catrina Anca Irinel; Sundberg Erik; Engström Marianne; Klareskog Lars; Ulfgren Ann-Kristin
Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
Arthritis research & therapy 2006;8(1):R18.
2005: Plenge Robert M; Padyukov Leonid; Remmers Elaine F; Purcell Shaun; Lee Annette T; Karlson Elizabeth W; Wolfe Frederick; Kastner Daniel L; Alfredsson Lars; Altshuler David; Gregersen Peter K; Klareskog Lars; Rioux John D
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4.
American journal of human genetics 2005;77(6):1044-60.
2005: af Klint Erik; Grundtman Cecilia; Engström Marianne; Catrina Anca Irinel; Makrygiannakis Dimitrios; Klareskog Lars; Andersson Ulf; Ulfgren Ann-Kristin
Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels.
Arthritis and rheumatism 2005;52(12):3880-9.
2005: Rönnelid J; Wick M C; Lampa J; Lindblad S; Nordmark B; Klareskog L; van Vollenhoven R F
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression.
Annals of the rheumatic diseases 2005;64(12):1744-9.
2005: Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
Annals of the rheumatic diseases 2005;64(12):1765-8.
2005: Korotkova Marina; Westman Marie; Gheorghe Karina R; af Klint Erik; Trollmo Christina; Ulfgren Ann Kristin; Klareskog Lars; Jakobsson Per-Johan
Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway.
Arthritis and rheumatism 2005;52(11):3439-47.
2005: van der Heijde D; Klareskog L; Boers M; Landewé R; Codreanu C; Bolosiu H D; Pedersen R; Fatenejad S;
Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results.
Annals of the rheumatic diseases 2005;64(11):1582-7.
2005: Bengtsson C; Nordmark B; Klareskog L; Lundberg I; Alfredsson L;
Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
Annals of the rheumatic diseases 2005;64(11):1588-94.
2005: Askling J; Fored C M; Baecklund E; Brandt L; Backlin C; Ekbom A; Sundström C; Bertilsson L; Cöster L; Geborek P; Jacobsson L T; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L; Feltelius N
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.
Annals of the rheumatic diseases 2005;64(10):1414-20.
2005: Askling J; Fored C M; Brandt L; Baecklund E; Bertilsson L; Feltelius N; Cöster L; Geborek P; Jacobsson L T; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists.
Annals of the rheumatic diseases 2005;64(10):1421-6.
2005: Wick M C; Ernestam S; Lindblad S; Bratt J; Klareskog L; van Vollenhoven R F
Adalimumab (Humira) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade) or etanercept (Enbrel): results from the STURE registry at Karolinska University Hospital.
Scandinavian journal of rheumatology 2005;34(5):353-8.
2005: Askling Johan; Fored C Michael; Brandt Lena; Baecklund Eva; Bertilsson Lennart; Cöster Lars; Geborek Pierre; Jacobsson Lennart T; Lindblad Staffan; Lysholm Jörgen; Rantapää-Dahlqvist Solbritt; Saxne Tore; Romanus Victoria; Klareskog Lars; Feltelius Nils
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.
Arthritis and rheumatism 2005;52(7):1986-92.
2005: Swanberg Maria; Lidman Olle; Padyukov Leonid; Eriksson Per; Akesson Eva; Jagodic Maja; Lobell Anna; Khademi Mohsen; Börjesson Ola; Lindgren Cecilia M; Lundman Pia; Brookes Anthony J; Kere Juha; Luthman Holger; Alfredsson Lars; Hillert Jan; Klareskog Lars; Hamsten Anders; Piehl Fredrik; Olsson Tomas
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
Nature genetics 2005;37(5):486-94.
2005: van Vollenhoven Ronald F; Klareskog Lars
The treatment of rheumatoid arthritis: getting better all the time?
Arthritis and rheumatism 2005;52(4):991-4.
2005: Stolt P; Källberg H; Lundberg I; Sjögren B; Klareskog L; Alfredsson L;
Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
Annals of the rheumatic diseases 2005;64(4):582-6.
2005: Larsson E; Harris H E; Palmblad K; Månsson B; Saxne T; Klareskog L
CNI-1493, an inhibitor of proinflammatory cytokines, retards cartilage destruction in rats with collagen induced arthritis.
Annals of the rheumatic diseases 2005;64(3):494-6.
2005: Hansson Tony; Dahlbom Ingrid; Rogberg Siv; Nyberg Britt-Inger; Dahlström Jörgen; Annerén Göran; Klareskog Lars; Dannaeus Anders
Antitissue transglutaminase and antithyroid autoantibodies in children with Down syndrome and celiac disease.
Journal of pediatric gastroenterology and nutrition 2005;40(2):170-4; discussion 125-7.
2005: Feltelius N; Fored C M; Blomqvist P; Bertilsson L; Geborek P; Jacobsson L T; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L;
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept.
Annals of the rheumatic diseases 2005;64(2):246-52.
2005: Catrina Anca Irinel; Trollmo Christina; af Klint Erik; Engstrom Marianne; Lampa Jon; Hermansson Ylva; Klareskog Lars; Ulfgren Ann Kristin
Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
Arthritis and rheumatism 2005;52(1):61-72.
2005: van der Heijde Désirée; Landewé Robert; Klareskog Lars; Rodríguez-Valverde Vicente; Settas Lucas; Pedersen Ronald; Fatenejad Saeed
Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study.
Arthritis and rheumatism 2005;52(1):49-60.
2005: Frostegård Johan; Svenungsson Elisabet; Wu Ruihua; Gunnarsson Iva; Lundberg Ingrid E; Klareskog Lars; Hörkkö Sohvi; Witztum Joseph L
Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
Arthritis and rheumatism 2005;52(1):192-200.
2005: Wick M C; Lindblad S; Weiss R J; Klareskog L; van Vollenhoven R F
Estimated prediagnosis radiological progression: an important tool for studying the effects of early disease modifying antirheumatic drug treatment in rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(1):134-7.
2005: Sverdrup Berit; Källberg Henrik; Bengtsson Camilla; Lundberg Ingvar; Padyukov Leonid; Alfredsson Lars; Klareskog Lars;
Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study.
Arthritis research & therapy 2005;7(6):R1296-303.
2005: Lundberg Karin; Nijenhuis Suzanne; Vossenaar Erik R; Palmblad Karin; van Venrooij Walter J; Klareskog Lars; Zendman A J W; Harris Helena Erlandsson
Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity.
Arthritis research & therapy 2005;7(3):R458-67.
2005: Malmström Vivianne; Trollmo Christina; Klareskog Lars
Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?
Arthritis research & therapy 2005;7 Suppl 2():S15-20.
2004: Rönnelid Johan; Klareskog Lars; Skogh Thomas; Svensson Björn
[Antibodies against citrullinated proteins--a breakthrough in rheumatologic diagnostics]
Läkartidningen 2004;101(50):4092-6.
2004: Klareskog L; Alfredsson L; Rantapää-Dahlqvist S; Berglin E; Stolt P; Padyukov L
What precedes development of rheumatoid arthritis?
Annals of the rheumatic diseases 2004;63 Suppl 2():ii28-ii31.
2004: Padyukov Leonid; Silva Camilla; Stolt Patrik; Alfredsson Lars; Klareskog Lars
A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis.
Arthritis and rheumatism 2004;50(10):3085-92.
2004: Jonsdottir T; Forslid J; van Vollenhoven A; Harju A; Brannemark S; Klareskog L; van Vollenhoven R F
Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.
Annals of the rheumatic diseases 2004;63(9):1075-8.
2004: Wick M C; Lindblad S; Klareskog L; Van Vollenhoven R F
Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description.
Annals of the rheumatic diseases 2004;63(7):848-52.
2004: Klareskog Lars; Hamsten Anders
Statins in rheumatoid arthritis--two birds with one stone?
Lancet 2004;363(9426):2011-2.
2004: Westman M; Korotkova M; af Klint E; Stark A; Audoly L P; Klareskog L; Ulfgren A-K; Jakobsson P-J
Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium.
Arthritis and rheumatism 2004;50(6):1774-80.
2004: Prokunina Ludmila; Padyukov Leonid; Bennet Anna; de Faire Ulf; Wiman Björn; Prince Jonathan; Alfredsson Lars; Klareskog Lars; Alarcón-Riquelme Marta
Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.
Arthritis and rheumatism 2004;50(6):1770-3.
2004: Baecklund Eva; Askling Johan; Rosenquist Richard; Ekbom Anders; Klareskog Lars
Rheumatoid arthritis and malignant lymphomas.
Current opinion in rheumatology 2004;16(3):254-61.
2004: Björnådal Lena; Yin Li; Granath Fredrik; Klareskog Lars; Ekbom Anders
Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.
The Journal of rheumatology 2004;31(4):713-9.
2004: Malmstrøm Vivianne; Trollmo Christina; Klareskog Lars
The additive role of innate and adaptive immunity in the development of arthritis.
The American journal of the medical sciences 2004;327(4):196-201.
2004: Larsson E; Erlandsson Harris H; Larsson A; Månsson B; Saxne T; Klareskog L
Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP.
Rheumatology (Oxford, England) 2004;43(4):428-34.
2004: van Vollenhoven R F; Brannemark S; Klareskog L
Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect.
Annals of the rheumatic diseases 2004;63(4):426-30.
2004: Padyukov Leonid; Hytönen Ann-Marie; Smolnikova Marina; Hahn-Zoric Mirjana; Nilsson Nicklas; Hanson Lars-Ake; Tarkowski Andrej; Klareskog Lars
Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women.
The Journal of rheumatology 2004;31(3):422-5.
2004: Lundberg Ingrid E; Grundtman Cecilia; Larsson Esbjörn; Klareskog Lars
Corticosteroids--from an idea to clinical use.
Best practice & research. Clinical rheumatology 2004;18(1):7-19.
2004: Klareskog Lars; Lindblad Staffan
How is clinical progress achieved?
Best practice & research. Clinical rheumatology 2004;18(1):1-5.
2004: Klareskog Lars; van der Heijde Désirée; de Jager Julien P; Gough Andrew; Kalden Joachim; Malaise Michel; Martín Mola Emilio; Pavelka Karel; Sany Jacques; Settas Lucas; Wajdula Joseph; Pedersen Ronald; Fatenejad Saeed; Sanda Marie;
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
Lancet 2004;363(9410):675-81.
2004: Svelander Lena; Erlandsson Harris Helena; Lorentzen Johnny C; Trollmo Christina; Klareskog Lars; Bucht Anders
Oligodeoxynucleotides containing CpG motifs can induce T cell-dependent arthritis in rats.
Arthritis and rheumatism 2004;50(1):297-304.
2004: van Vollenhoven R F; Gunnarsson I; Welin-Henriksson E; Sundelin B; Osterborg A; Jacobson S H; Klareskog L
Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone.
Scandinavian journal of rheumatology 2004;33(6):423-7.
2004: Wick M C; Lindblad S; Weiss R J; Klareskog L; van Vollenhoven R F
Clinical and radiological disease-course in a Swedish DMARD-treated early RA-inception cohort: an observational study.
Scandinavian journal of rheumatology 2004;33(6):380-4.
2004: Cao Duojia; van Vollenhoven Ronald; Klareskog Lars; Trollmo Christina; Malmström Vivianne
CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease.
Arthritis research & therapy 2004;6(4):R335-46.
2004: Berglin Ewa; Padyukov Leonid; Sundin Ulf; Hallmans Göran; Stenlund Hans; Van Venrooij Walther J; Klareskog Lars; Dahlqvist Solbritt Rantapää
A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.
Arthritis research & therapy 2004;6(4):R303-8.
2003: van Vollenhoven R; Harju A; Brannemark S; Klareskog L
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense.
Annals of the rheumatic diseases 2003;62(12):1195-8.
2003: Svenungsson Elisabet; Gunnarsson Iva; Fei Guo-Zhong; Lundberg Ingrid E; Klareskog Lars; Frostegård Johan
Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
Arthritis and rheumatism 2003;48(9):2533-40.
2003: Stolt P; Bengtsson C; Nordmark B; Lindblad S; Lundberg I; Klareskog L; Alfredsson L;
Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases.
Annals of the rheumatic diseases 2003;62(9):835-41.
2003: Ernestam Sofia; Lampa Jon; Rogberg Siv; Rönnelid Johan; Klareskog Lars; Hafström Ingiäld
Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions.
The Journal of rheumatology 2003;30(8):1748-55.
2003: Baecklund Eva; Sundström Christer; Ekbom Anders; Catrina Anca I; Biberfeld Peter; Feltelius Nils; Klareskog Lars
Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma.
Arthritis and rheumatism 2003;48(6):1543-50.
2003: van Vollenhoven Ronald F; Klareskog Lars
Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry.
Arthritis and rheumatism 2003;48(6):1500-3.
2003: Padyukov L; Lampa J; Heimbürger M; Ernestam S; Cederholm T; Lundkvist I; Andersson P; Hermansson Y; Harju A; Klareskog L; Bratt J
Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.
Annals of the rheumatic diseases 2003;62(6):526-9.
2003: Ekström Karin; Hjalgrim Henrik; Brandt Lena; Baecklund Eva; Klareskog Lars; Ekbom Anders; Askling Johan
Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.
Arthritis and rheumatism 2003;48(4):963-70.
2003: Klareskog Lars; Efendic Suad; Brismar Kerstin; Hamsten Anders
[The proposal of the National Board of Health and Welfare counteracts knowledge development within health care]
Läkartidningen 2003;100(8):631-2.
2003: Cao Duojia; Malmström Vivianne; Baecher-Allan Clare; Hafler David; Klareskog Lars; Trollmo Christina
Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis.
European journal of immunology 2003;33(1):215-23.
2003: van Vollenhoven Ronald F; Ernestam Sofia; Harju Anders; Bratt Johan; Klareskog Lars
Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious.
Arthritis research & therapy 2003;5(6):R347-51.
2002: Thunberg Ulf; Tobin Gerard; Johnson Anna; Söderberg Ola; Padyukov Leonid; Hultdin Magnus; Klareskog Lars; Enblad Gunilla; Sundström Christer; Roos Göran; Rosenquist Richard
Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia.
Lancet 2002;360(9349):1935-9.
2002: Hansson T; Ulfgren A-K; Lindroos E; DannAEus A; Dahlbom I; Klareskog L
Transforming growth factor-beta (TGF-beta) and tissue transglutaminase expression in the small intestine in children with coeliac disease.
Scandinavian journal of immunology 2002;56(5):530-7.
2002: Catrina A I; Ulfgren A K; Lindblad S; Grondal L; Klareskog L
Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium.
Annals of the rheumatic diseases 2002;61(10):934-6.
2002: Larsson E; Erlandsson Harris H; Lorentzen J C; Larsson A; Månsson B; Klareskog L; Saxne T
Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats.
Rheumatology (Oxford, England) 2002;41(9):996-1000.
2002: Hansson Tony; Dahlbom Ingrid; Rogberg Siv; Dannaeus Anders; Hopfl Peter; Gut Heidi; Kraaz Wolfgang; Klareskog Lars
Recombinant human tissue transglutaminase for diagnosis and follow-up of childhood coeliac disease.
Pediatric research 2002;51(6):700-5.
2002: Björnådal Lena; Baecklund Eva; Yin Li; Granath Fredrik; Klareskog Lars; Ekbom Anders
Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95.
The Journal of rheumatology 2002;29(5):906-12.
2002: Catrina A I; Lampa J; Ernestam S; af Klint E; Bratt J; Klareskog L; Ulfgren A-K
Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis.
Rheumatology (Oxford, England) 2002;41(5):484-9.
2002: Englund Pernilla; Nennesmo Inger; Klareskog Lars; Lundberg Ingrid E
Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue.
Arthritis and rheumatism 2002;46(4):1044-55.
2002: Lampa Jon; Klareskog Lars; Rönnelid Johan
Effects of gold on cytokine production in vitro; increase of monocyte dependent interleukin 10 production and decrease of interferon-gamma levels.
The Journal of rheumatology 2002;29(1):21-8.
2002: Gröndal G; Traustadottir K H; Kristjansdottir H; Lundberg I; Klareskog L; Erlendsson K; Steinsson K
Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families.
Lupus 2002;11(7):435-42.
2002: Klareskog Lars; Lorentzen Johnny; Padyukov Leonid; Alfredsson Lars
Genes and environment in arthritis: can RA be prevented?
Arthritis research 2002;4 Suppl 3():S31-6.
2001: Hafström I; Ringertz B; Spångberg A; von Zweigbergk L; Brannemark S; Nylander I; Rönnelid J; Laasonen L; Klareskog L
A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens.
Rheumatology (Oxford, England) 2001;40(10):1175-9.
2001: Englund P; Lindroos E; Nennesmo I; Klareskog L; Lundberg I E
Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies.
The American journal of pathology 2001;159(4):1263-73.
2001: Svenungsson E; Andersson M; Brundin L; van Vollenhoven R; Khademi M; Tarkowski A; Greitz D; Dahlström M; Lundberg I; Klareskog L; Olsson T
Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.
Annals of the rheumatic diseases 2001;60(4):372-9.
2001: Klareskog L; Nordmark B; Lindblad S
On the organization of an early arthritis clinic.
Best practice & research. Clinical rheumatology 2001;15(1):1-15.
2001: Larsson P; Bratt J; Harju A; van Vollenhoven R; Klareskog L
[Blockade of TNFalpha--new therapeutic principle in severe rheumatoid arthritis]
Läkartidningen 2001;98(8):828-31.
2001: Berg L; Lampa J; Rogberg S; van Vollenhoven R; Klareskog L
Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors.
Annals of the rheumatic diseases 2001;60(2):133-9.
2001: Hassan A B; Gunnarsson I; Karlsson G; Klareskog L; Forslid J; Lundberg I E
Longitudinal study of interleukin-10, tumor necrosis factor-alpha, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease.
Scandinavian journal of rheumatology 2001;30(5):282-9.
2000: Magnusson V; Lindqvist A K; Castillejo-López C; Kristjánsdottir H; Steinsson K; Gröndal G; Sturfelt G; Truedsson L; Svenungsson E; Lundberg I; Gunnarsson I; Bolstad A I; Haga H J; Jonsson R; Klareskog L; Alcocer-Varela J; Alarcón-Segovia D; Terwilliger J D; Gyllensten U B; Alarcón-Riquelme M E
Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus.
Genomics 2000;70(3):307-14.
2000: Klareskog L; Hafström I; Saxne T; Hedin P J
[New drugs against rheumatoid arthritis. Improved treatment options place new demands on health care organization]
Läkartidningen 2000;97(48):5628-32.
2000: Ulfgren A K; Andersson U; Engström M; Klareskog L; Maini R N; Taylor P C
Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.
Arthritis and rheumatism 2000;43(11):2391-6.
2000: Gröndal G; Gunnarsson I; Rönnelid J; Rogberg S; Klareskog L; Lundberg I
Cytokine production, serum levels and disease activity in systemic lupus erythematosus.
Clinical and experimental rheumatology 2000;18(5):565-70.
2000: Gunnarsson I; Nordmark B; Hassan Bakri A; Gröndal G; Larsson P; Forslid J; Klareskog L; Ringertz B
Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA.
Rheumatology (Oxford, England) 2000;39(8):886-93.
2000: Ulfgren A K; Gröndal L; Lindblad S; Khademi M; Johnell O; Klareskog L; Andersson U
Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.
Annals of the rheumatic diseases 2000;59(6):439-47.
2000: Blomqvist P; Feltelius N; Ekbom A; Klareskog L
Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.
The Journal of rheumatology 2000;27(5):1171-7.
2000: Lundberg I; Antohi S; Takeuki K; Arnett F; Steiner G; Brumeanu T D; Klareskog L; Bona C
Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome.
Journal of autoimmunity 2000;14(3):267-74.
2000: Klareskog L
[Current medicine requires cooperation--not omnipotence]
Läkartidningen 2000;97(17):2110-1.
2000: Hansson T; Dahlbom I; Hall J; Holtz A; Elfman L; Dannaeus A; Klareskog L
Antibody reactivity against human and guinea pig tissue transglutaminase in children with celiac disease.
Journal of pediatric gastroenterology and nutrition 2000;30(4):379-84.
2000: Berg L; Rönnelid J; Klareskog L; Bucht A
Down-regulation of the T cell receptor CD3 zeta chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness.
Clinical and experimental immunology 2000;120(1):174-82.
2000: Klareskog L; Lundberg I
[Future treatment of rheumatism. A compromise in the game between inflammation and infections]
Läkartidningen 2000;97(1-2):30-3.
2000: Berg L; Rönnelid J; Sanjeevi C B; Lampa J; Klareskog L
Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Arthritis research 2000;2(1):75-84.
1999: Klareskog L; McDevitt H
Rheumatoid arthritis and its animal models: the role of TNF-alpha and the possible absence of specific immune reactions.
Current opinion in immunology 1999;11(6):657-62.
1999: Alarcón-Riquelme M E; Lindqvist A K; Jonasson I; Johanneson B; Sandino S; Alcocer-Varela J; Granados J; Kristjánsdóttir H; Gröndal G; Svenungsson E; Lundberg I; Steinsson K; Klareskog L; Sturfelt G; Truedsson L; Alarcón-Segovia D; Gyllensten U B
Genetic analysis of the contribution of IL10 to systemic lupus erythematosus.
The Journal of rheumatology 1999;26(10):2148-52.
1999: Hansson T; Annerén G; Sjöberg O; Klareskog L; Dannaeus A
Celiac disease in relation to immunologic serum markers, trace elements, and HLA-DR and DQ antigens in Swedish children with Down syndrome.
Journal of pediatric gastroenterology and nutrition 1999;29(3):286-92.
1999: Gröndal G; Kristjansdottir H; Gunnlaugsdottir B; Arnason A; Lundberg I; Klareskog L; Steinsson K
Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families.
Arthritis and rheumatism 1999;42(8):1649-54.
1999: Johanneson B; Steinsson K; Lindqvist A K; Kristjánsdóttir H; Gröndal G; Sandino S; Tjernström F; Sturfelt G; Granados-Arriola J; Alcocer-Varela J; Lundberg I; Jonasson I; Truedsson L; Svenungsson E; Klareskog L; Alarcón-Segovia D; Gyllensten U B; Alarcón-Riquelme M E
A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups.
Journal of autoimmunity 1999;13(1):137-41.
1999: Hansson T; Dannaeus A; Klareskog L
Cytokine-producing cells in peripheral blood of children with coeliac disease secrete cytokines with a type 1 profile.
Clinical and experimental immunology 1999;116(2):246-50.
1999: Mattsson L; Klareskog L; Lorentzen J C
Susceptibility of rats to homologous collagen-induced arthritis depends on MHC genes in the class II region.
Transplantation proceedings 1999;31(3):1594-6.
1998: Larsson P; Mattsson L; Klareskog L; Johnsson C
A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia.
Clinical and experimental immunology 1998;114(2):277-83.
1998: Lorentzen J C; Glaser A; Jacobsson L; Galli J; Fakhrai-rad H; Klareskog L; Luthman H
Identification of rat susceptibility loci for adjuvant-oil-induced arthritis.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(11):6383-7.
1998: Matsuda M; Ulfgren A K; Lenkei R; Petersson M; Ochoa A C; Lindblad S; Andersson P; Klareskog L; Kiessling R
Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of rheumatoid arthritis patients.
Scandinavian journal of immunology 1998;47(3):254-62.
1998: Rönnelid J; Berg L; Rogberg S; Nilsson A; Albertsson K; Klareskog L
Production of T-cell cytokines at the single-cell level in patients with inflammatory arthritides: enhanced activity in synovial fluid compared to blood.
British journal of rheumatology 1998;37(1):7-14.
1998: Sverdrup B; Klareskog L; Kleinau S
Common commercial cosmetic products induce arthritis in the DA rat.
Environmental health perspectives 1998;106(1):27-32.
1997: Larsson E; Müssener A; Heinegård D; Klareskog L; Saxne T
Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis.
British journal of rheumatology 1997;36(12):1258-61.
1997: Mattsson L; Lorentzen J C; Svelander L; Bucht A; Nyman U; Klareskog L; Larsson P
Immunization with alum-collagen II complex suppresses the development of collagen-induced arthritis in rats by deviating the immune response.
Scandinavian journal of immunology 1997;46(6):619-24.
1997: Nyman U; Müssener A; Larsson E; Lorentzen J; Klareskog L
Amelioration of collagen II-induced arthritis in rats by the type IV phosphodiesterase inhibitor Rolipram.
Clinical and experimental immunology 1997;108(3):415-9.
1997: Lundberg I; Ulfgren A K; Nyberg P; Andersson U; Klareskog L
Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
Arthritis and rheumatism 1997;40(5):865-74.
1997: Lorentzen J C; Klareskog L
Comparative susceptibility of DA, LEW, and LEW.1AV1 rats to arthritis induced with different arthritogens: mineral oil, mycobacteria, muramyl dipeptide, avridine and rat collagen type II.
Transplantation proceedings 1997;29(3):1692-3.
1997: Hansson T; Dannaeus A; Kraaz W; Sjöberg O; Klareskog L
Production of antibodies to gliadin by peripheral blood lymphocytes in children with celiac disease: the use of an enzyme-linked immunospot technique for screening and follow-up.
Pediatric research 1997;41(4 Pt 1):554-9.
1997: Müssener A; Lorentzen J C; Kleinau S; Klareskog L
Altered Th1/Th2 balance associated with non-major histocompatibility complex genes in collagen-induced arthritis in resistant and non-resistant rat strains.
European journal of immunology 1997;27(3):695-9.
1997: Müssener A; Litton M J; Lindroos E; Klareskog L
Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA).
Clinical and experimental immunology 1997;107(3):485-93.
1997: Erlandsson Harris H; Liljeström M; Klareskog L
Characteristics of synovial fluid effusion in collagen-induced arthritis (CIA) in the DA rat; a comparison of histology and antibody reactivities in an experimental chronic arthritis model and rheumatoid arthritis (RA).
Clinical and experimental immunology 1997;107(3):480-4.
1997: Gunnarsson I; Rönnelid J; Huang Y H; Rogberg S; Nilsson B; Lundberg I; Klareskog L
Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.
British journal of rheumatology 1997;36(1):32-7.
1997: Klareskog L
[New perspectives on rheumatoid arthritis]
Läkartidningen 1997;94(1-2):24-7.
1997: Müssener A; Funa K; Kleinau S; Klareskog L
Dynamic expression of transforming growth factor-betas (TGF-beta) and their type I and type II receptors in the synovial tissue of arthritic rats.
Clinical and experimental immunology 1997;107(1):112-9.
1996: Lorentzen J C; Klareskog L
Susceptibility of DA rats to arthritis induced with adjuvant oil or rat collagen is determined by genes both within and outside the major histocompatibility complex.
Scandinavian journal of immunology 1996;44(6):592-8.
1996: Hellman P; Karlsson-Parra A; Klareskog L; Ridefelt P; Bjerneroth G; Rastad J; Akerström G; Juhlin C
Expression and function of a CD4-like molecule in parathyroid tissue.
Surgery 1996;120(6):985-92.
1995: Lorentzen J C; Issazadeh S; Storch M; Mustafa M I; Lassman H; Linington C; Klareskog L; Olsson T
Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant.
Journal of neuroimmunology 1995;63(2):193-205.
1995: Hellman P; Juhlin C; Karlsson-Parra A; Klareskog L; Ridefelt P; Rastad J; Akerström G
Expression and function of a CD3-like molecule on normal and abnormal human parathyroid cells.
Surgery 1995;118(6):1055-61; discussion 1062.
1995: Klareskog L; Rönnelid J; Holm G
Immunopathogenesis and immunotherapy in rheumatoid arthritis: an area in transition.
Journal of internal medicine 1995;238(3):191-206.
1995: Ulfgren A K; Lindblad S; Klareskog L; Andersson J; Andersson U
Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis.
Annals of the rheumatic diseases 1995;54(8):654-61.
1995: Erlandsson H; Müssener A; Klareskog L; Gold D P
Restricted T-cell receptor usage in DA rats during early collagen-induced arthritis.
Annals of the New York Academy of Sciences 1995;756():225-6.
1995: Müssener A; Klareskog L; Lorentzen J C; Kleinau S
TNF-alpha dominates cytokine mRNA expression in lymphoid tissues of rats developing collagen- and oil-induced arthritis.
Scandinavian journal of immunology 1995;42(1):128-34.
1995: Lorentzen J C; Erlandsson H; Müssener A; Mattsson L; Kleinau S; Nyman U; Klareskog L
Specific and long-lasting protection from collagen-induced arthritis and oil-induced arthritis in DA rats by administration of immunogens.
Scandinavian journal of immunology 1995;42(1):82-9.
1995: Kleinau S; Dencker L; Klareskog L
Oil-induced arthritis in DA rats: tissue distribution of arthritogenic 14C-labelled hexadecane.
International journal of immunopharmacology 1995;17(5):393-401.
1995: Lorentzen J C; Olsson T; Klareskog L
Susceptibility to oil-induced arthritis in the DA rat is determined by MHC and non-MHC genes.
Transplantation proceedings 1995;27(2):1532-4.
1995: Rönnelid J; Klareskog L
Local versus systemic immunoreactivity to collagen and the collage-like region of C1q in rheumatoid arthritis and SLE.
Scandinavian journal of rheumatology. Supplement 1995;101():57-61.
1995: Kleinau S; Lorentzen J; Klareskog L
Role of adjuvants in turning autoimmunity into autoimmune disease.
Scandinavian journal of rheumatology. Supplement 1995;101():179-81.
1994: Björk J; Kleinau S; Midtvedt T; Klareskog L; Smedegård G
Role of the bowel flora for development of immunity to hsp 65 and arthritis in three experimental models.
Scandinavian journal of immunology 1994;40(6):648-52.
1994: Erlandsson H; Müssener A; Klareskog L; Gold D P
Restricted T cell receptor usage in DA rats during early collagen-induced arthritis.
European journal of immunology 1994;24(8):1929-32.
1994: Rönnelid J; Huang Y H; Norrlander T; Rogberg S; Nilsson B; Gustafsson R; Klareskog L
Short-term kinetics of the humoral anti-C1q response in SLE using the ELISPOT method: fast decline in production in response to steroids.
Scandinavian journal of immunology 1994;40(2):243-50.
1994: Rönnelid J; Lysholm J; Engström-Laurent A; Klareskog L; Heyman B
Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response.
Arthritis and rheumatism 1994;37(7):1023-9.
1994: Kleinau S; Erlandsson H; Klareskog L
Percutaneous exposure of adjuvant oil causes arthritis in DA rats.
Clinical and experimental immunology 1994;96(2):281-4.
1994: Hellman P; Albert J; Gidlund M; Klareskog L; Rastad J; Akerström G; Juhlin C
Impaired parathyroid hormone release in human immunodeficiency virus infection.
AIDS research and human retroviruses 1994;10(4):391-4.
1993: Bjerneroth G; Juhlin C; Rastad J; Akerström G; Klareskog L
MHC class I and II antigen expression on parathyroid cells and prospects for their allogenic transplantation.
Transplantation 1993;56(3):717-21.
1993: Heyman B; Gustavsson S; Kusakari C; Nose M; Kinoshita T; Klareskog L; Tarkowski A
Antibody feedback regulation in MRL/lpr mice.
Journal of autoimmunity 1993;6(4):437-48.
1993: Kleinau S; Klareskog L
Oil-induced arthritis in DA rats passive transfer by T cells but not with serum.
Journal of autoimmunity 1993;6(4):449-58.
1992: Gudmundsson S; Rönnelid J; Karlsson-Parra A; Lysholm J; Gudbjörnsson B; Widenfalk B; Janson C H; Klareskog L
T-cell receptor V-gene usage in synovial fluid and synovial tissue from RA patients.
Scandinavian journal of immunology 1992;36(5):681-8.
1992: Nordling C; Kleinau S; Klareskog L
Down-regulation of a spontaneous arthritis in male DBA/1 mice after administration of monoclonal anti-idiotypic antibodies to a cross-reactive idiotope on anti-collagen antibodies.
Immunology 1992;77(1):144-6.
1992: Edelstam G A; Lundkvist O E; Klareskog L; Karlsson-Parra A
Cyclic variation of major histocompatibility complex class II antigen expression in the human fallopian tube epithelium.
Fertility and sterility 1992;57(6):1225-9.
1992: Nordling C; Karlsson-Parra A; Jansson L; Holmdahl R; Klareskog L
Characterization of a spontaneously occurring arthritis in male DBA/1 mice.
Arthritis and rheumatism 1992;35(6):717-22.
1992: Wells A F; Klareskog L; Lindblad S; Laurent T C
Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells. A role for macrophage-derived factors.
Arthritis and rheumatism 1992;35(4):391-6.
1992: Wanders A; Wells A F; Tufveson G; Klareskog L
Gamma-interferon-like substance is expressed in myocytes of cardiac allografted rats treated with cyclosporine A.
Transplantation proceedings 1992;24(1):346.
1992: Bucht A; Oksenberg J R; Lindblad S; Grönberg A; Steinman L; Klareskog L
Characterization of T-cell receptor alpha beta repertoire in synovial tissue from different temporal phases of rheumatoid arthritis.
Scandinavian journal of immunology 1992;35(2):159-65.
1992: Wanders A; Wells A F; Larsson E; Tufveson G; Olsson T; Ljungdahl A; Klareskog L
Expression of an interferon-gamma-like substance in normal and transplanted rat heart tissue.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1992;11(1 Pt 1):142-6.
1991: Kleinau S; Erlandsson H; Holmdahl R; Klareskog L
Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement.
Journal of autoimmunity 1991;4(6):871-80.
1991: Klareskog L; Rönnelid J; Gudmundsson S; Karlsson-Parra A
Rheumatoid arthritis.
Current opinion in immunology 1991;3(6):912-6.
1991: Kiessling R; Grönberg A; Ivanyi J; Söderström K; Ferm M; Kleinau S; Nilsson E; Klareskog L
Role of hsp60 during autoimmune and bacterial inflammation.
Immunological reviews 1991;121():91-111.
1991: Nordling C; Holmdahl R; Klareskog L
A monoclonal antiidiotypic antibody with rheumatoid factor activity defines a cross-reactive idiotope on murine anticollagen antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(12):4258-63.
1991: Feltelius N; Gudmundsson S; Wennersten L; Sjöberg O; Hällgren R; Klareskog L
Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides.
Annals of the rheumatic diseases 1991;50(6):369-71.
1991: Nordling C; Holmdahl R; Klareskog L
Down-regulation of collagen arthritis after in vivo treatment with a syngeneic monoclonal anti-idiotypic antibody to a cross-reactive idiotope on collagen II auto-antibodies.
Immunology 1991;72(4):486-90.
1991: Kleinau S; Söderström K; Kiessling R; Klareskog L
A monoclonal antibody to the mycobacterial 65 kDa heat shock protein (ML 30) binds to cells in normal and arthritic joints of rats.
Scandinavian journal of immunology 1991;33(2):195-202.
1991: Klareskog L
Antigen presentation in joints in the pathogenesis of arthritis.
British journal of rheumatology 1991;30 Suppl 1():53-7.
1990: Klareskog L; Olsson T
Autoimmunity to collagen II and myelin basic protein: comparative studies in humans and rodents.
Immunological reviews 1990;118():285-310.
1990: Wells A F; Larsson E; Tengblad A; Fellström B; Tufveson G; Klareskog L; Laurent T C
The localization of hyaluronan in normal and rejected human kidneys.
Transplantation 1990;50(2):240-3.
1990: Karlsson-Parra A; Burman P; Hagberg H; Oberg K; Alm G; Klareskog L; Karlsson F A
Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-alpha (IFN-alpha).
Clinical and experimental immunology 1990;81(1):72-5.
1990: Karlsson-Parra A; Söderström K; Ferm M; Ivanyi J; Kiessling R; Klareskog L
Presence of human 65 kD heat shock protein (hsp) in inflamed joints and subcutaneous nodules of RA patients.
Scandinavian journal of immunology 1990;31(6):283-8.
1990: Larsson P; Kleinau S; Holmdahl R; Klareskog L
Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation.
Arthritis and rheumatism 1990;33(5):693-701.
1990: Gylfe E; Juhlin C; Akerström G; Klareskog L; Rask L; Rastad J
Monoclonal antiparathyroid antibodies--tools for studies of the regulation of cytoplasmic calcium and function of parathyroid and other antibody-reactive cells.
Cell calcium 1990;11(5):329-32.
1989: Fellström B; Klareskog L; Heldin C H; Larsson E; Rönnstrand L; Terracio L; Tufveson G; Wahlberg J; Rubin K
Platelet-derived growth factor receptors in the kidney--upregulated expression in inflammation.
Kidney international 1989;36(6):1099-102.
1989: Karlsson-Parra A; Dimény E; Juhlin C; Fellström B; Klareskog L
The anti-Leu4 (CD3) monoclonal antibody reacts with proximal tubular cells of the human kidney.
Scandinavian journal of immunology 1989;30(6):719-22.
1989: Larsson P; Goldschmidt T J; Klareskog L; Holmdahl R
Oestrogen-mediated suppression of collagen-induced arthritis in rats. Studies on the role of the thymus and of peripheral CD8+ T lymphocytes.
Scandinavian journal of immunology 1989;30(6):741-7.
1989: Kleinau S; Larsson P; Björk J; Holmdahl R; Klareskog L
Linomide, a new immunomodulatory drug, shows different effects on homologous versus heterologous collagen-induced arthritis in rats.
Clinical and experimental immunology 1989;78(1):138-42.
1989: Tarkowski A; Klareskog L; Carlsten H; Herberts P; Koopman W J
Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis.
Arthritis and rheumatism 1989;32(9):1087-92.
1989: Holmdahl R; Mo J; Nordling C; Larsson P; Jansson L; Goldschmidt T; Andersson M; Klareskog L
Collagen induced arthritis: an experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanisms.
Clinical and experimental rheumatology 1989;7 Suppl 3():S51-5.
1989: Juhlin C; Rastad J; Klareskog L; Grimelius L; Akerström G
Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells.
The American journal of pathology 1989;135(2):321-8.
1989: Larsson P; Holmdahl R; Klareskog L
In vivo treatment with anti-CD8 and anti-CD5 monoclonal antibodies alters induced tolerance to adjuvant arthritis.
Journal of cellular biochemistry 1989;40(1):49-56.
1989: Karlsson-Parra A; Dimény E; Fellström B; Klareskog L
HIV receptors (CD4 antigen) in normal human glomerular cells.
The New England journal of medicine 1989;320(11):741.
1989: Holmdahl R; Bailey C; Enander I; Mayer R; Klareskog L; Moran T; Bona C
Origin of the autoreactive anti-type II collagen response. II. Specificities, antibody isotypes and usage of V gene families of anti-type II collagen B cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(6):1881-6.
1989: Allebeck P; Adami H O; Klareskog L; Persson I
Non-contraceptive hormones and rheumatoid arthritis: possibilities of using a Swedish population-based cohort.
British journal of rheumatology 1989;28 Suppl 1():38-40; discussion 42-5.
1989: Klareskog L
What can we learn about rheumatoid arthritis from animal models?
Springer seminars in immunopathology 1989;11(3):315-33.
1989: Tarkowski A; Holmdahl R; Klareskog L
Rheumatoid factors in mice.
Monographs in allergy 1989;26():214-29.
1988: Mauritz N J; Holmdahl R; Jonsson R; Van der Meide P H; Scheynius A; Klareskog L
Treatment with gamma-interferon triggers the onset of collagen arthritis in mice.
Arthritis and rheumatism 1988;31(10):1297-304.
1988: Holmdahl R; Andersson M; Enander I; Goldschmidt T; Jansson L; Larsson P; Mo J; Nordling C; Klareskog L
Nature of the type II collagen autoimmunity in mice susceptible to collagen-induced arthritis.
International reviews of immunology 1988;4(1):49-64.
1988: Karlsson-Parra A; Kobbah M; Ewald U; Tuvemo T; Forsum U; Klareskog L
Circulating class II transplantation antigen-expressing T lymphocytes in children with insulin-dependent diabetes mellitus at diagnosis.
Acta paediatrica Scandinavica 1988;77(4):554-8.
1988: Goldschmidt T J; Holmdahl R; Klareskog L
Depletion of murine T cells by in vivo monoclonal antibody treatment is enhanced by adding an autologous anti-rat kappa chain antibody.
Journal of immunological methods 1988;111(2):219-26.
1988: Claesson K; Mjörnstedt L; Klareskog L; Larsson E; Olausson M; Söderström T; Brynger H; Tufveson G
Morphologic and immunohistochemical changes in antithymocyte globulin-induced permanently surviving rat cardiac allografts.
Transplantation proceedings 1988;20(3):523-4.
1988: Rubin K; Tingström A; Hansson G K; Larsson E; Rönnstrand L; Klareskog L; Claesson-Welsh L; Heldin C H; Fellström B; Terracio L
Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions.
Lancet 1988;1(8599):1353-6.
1988: Juhlin C; Klareskog L; Nygren P; Ljunghall S; Gylfe E; Rastad J; Akerström G
Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies.
Endocrinology 1988;122(6):2999-3001.
1988: Czerkinsky C; Andersson G; Ekre H P; Nilsson L A; Klareskog L; Ouchterlony O
Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells.
Journal of immunological methods 1988;110(1):29-36.
1988: Tarkowski A; Jonsson R; Sanchez R; Klareskog L; Koopman W J
Features of renal vasculitis in autoimmune MRL lpr/lpr mice: phenotypes and functional properties of infiltrating cells.
Clinical and experimental immunology 1988;72(1):91-7.
1988: Rubin K; Terracio L; Rönnstrand L; Heldin C H; Klareskog L
Expression of platelet-derived growth factor receptors is induced on connective tissue cells during chronic synovial inflammation.
Scandinavian journal of immunology 1988;27(3):285-94.
1988: Claesson K; Mjörnstedt L; Klareskog L; Larsson E; Olausson M; Söderström T
Morphology of rat cardiac allografts with permanent survival induced by antithymocyte globulin.
Scandinavian journal of immunology 1988;27(2):171-9.
1988: Holmdahl R; Jonsson R; Larsson P; Klareskog L
Early appearance of activated CD4+ T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen.
Laboratory investigation; a journal of technical methods and pathology 1988;58(1):53-60.
1988: Nordling C; Klareskog L
Interactions between the immune system and connective tissue in arthritis. Possible significance of an affinity between IgG and native type II collagen.
Scandinavian journal of rheumatology. Supplement 1988;74():73-8.
1988: Klareskog L; Johnell O
Induced expression of class II transplantation antigens in the cartilage-pannus junction in RA: chronic synovitis as a model system for aberrant T-lymphocyte activation.
British journal of rheumatology 1988;27 Suppl 2():141-9.
1988: Gudmundsson S; Sjöberg O; Klareskog L
Interactions between the immune system and connective tissue in arthritis: aspects on T-cell activation.
Scandinavian journal of rheumatology. Supplement 1988;76():117-24.
1987: Holmdahl R; Jansson L; Meyerson B; Klareskog L
Oestrogen induced suppression of collagen arthritis: I. Long term oestradiol treatment of DBA/1 mice reduces severity and incidence of arthritis and decreases the anti type II collagen immune response.
Clinical and experimental immunology 1987;70(2):372-8.
1987: Jonsson R; Klareskog L; Bäckman K; Tarkowski A
Expression of HLA-D-locus (DP, DQ, DR)-coded antigens, beta 2-microglobulin, and the interleukin 2 receptor in Sjögren's syndrome.
Clinical immunology and immunopathology 1987;45(2):235-43.
1987: Holmdahl R; Tarkowski A; Nordling C; Rubin K; Klareskog L
Connection between autoimmunity to cartilage type II collagen and rheumatoid factor production.
Monographs in allergy 1987;22():71-80.
1987: Klareskog L; Holmdahl R; Goldschmidt T; Björk J
Immunoregulation in arthritis. A review on synovial immune reactions in RA and in some experimental animal models for arthritis.
Scandinavian journal of rheumatology. Supplement 1987;64():7-15.
1987: Klareskog L; Holmdahl R; Nordling C; Tarkowski A; Rubin K
Synovial class II antigen expression and immune complex formation in rheumatoid arthritis.
Acta medica Scandinavica. Supplementum 1987;715():85-91.
1986: Holmdahl R; Klareskog L; Rubin K; Björk J; Smedegård G; Jonsson R; Andersson M
Role of T lymphocytes in murine collagen induced arthritis.
Agents and actions 1986;19(5-6):295-305.
1986: Holmdahl R; Nordling C; Rubin K; Tarkowski A; Klareskog L
Generation of monoclonal rheumatoid factors after immunization with collagen II-anti-collagen II immune complexes. An anti-idiotypic antibody to anti-collagen II is also a rheumatoid factor.
Scandinavian journal of immunology 1986;24(2):197-203.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Lars Klareskog

Research Profile (preview)

Disorders

Chemicals & Drugs

Geographic Areas

Living Beings

Anatomy

Procedures

Physiology

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Lars Klareskog (preview)

All Publications